Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sahar Mortezagholi, Zohreh Babaloo, Parisa Rahimzadeh, Haideh Namdari, Mojgan Ghaedi, Farhad Gharibdoost, Reza Mirzaei, Katayoon Bidad & Eisa Salehi. (2017) Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients. Immunopharmacology and Immunotoxicology 39:1, pages 11-18.
Read now
Read now
Yutaka Kuwatsuka, Fumihide Ogawa, Yohei Iwata, Kazuhiro Komura, Eiji Muroi, Toshihide Hara, Motoi Takenaka, Kazuhiro Shimizu, Minoru Hasegawa, Manabu Fujimoto & Shinichi Sato. (2009) Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis. Autoimmunity 42:2, pages 120-125.
Read now
Read now
Muhammad Wasif Saif, Antonis Zalonis & Kostas Syrigos. (2007) The clinical significance of autoantibodies in gastrointestinal malignancies: an overview. Expert Opinion on Biological Therapy 7:4, pages 493-507.
Read now
Read now
Articles from other publishers (19)
Ao HoHsieh, Chin Man Wang, Yeong-Jian Jan Wu, Albert Chen, Ming-I Chang & Ji-Yih Chen. (2017) B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Helena Enocsson, Christopher Sjöwall, Lina Wirestam, Charlotte Dahle, Alf Kastbom, Johan Rönnelid, Jonas Wetterö & Thomas Skogh. (2015) Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity. The Journal of Rheumatology 42:5, pages 817-825.
Crossref
Crossref
Marvin J Fritzler. (2014) Perspectives on the imperatives, opportunities and challenges for point-of-care diagnostics in systemic lupus erythematosus. International Journal of Clinical Rheumatology 9:5, pages 449-456.
Crossref
Crossref
Christiane S. Hampe. (2012) B Cells in Autoimmune Diseases. Scientifica 2012, pages 1-18.
Crossref
Crossref
Nils Boehm, Dominik Wolters, Uta Thiel, Ulrike Lossbrand, Nelli Wiegel, Norbert Pfeiffer & Franz H. Grus. (2012) New insights into autoantibody profiles from immune privileged sites in the eye: A glaucoma study. Brain, Behavior, and Immunity 26:1, pages 96-102.
Crossref
Crossref
Zhan Huang, Binqing Fu, Song Guo Zheng, Xiaomei Li, Rui Sun, Zhigang Tian & Haiming Wei. (2011) Involvement of CD226+ NK Cells in Immunopathogenesis of Systemic Lupus Erythematosus. The Journal of Immunology 186:6, pages 3421-3431.
Crossref
Crossref
S. Sohl, R. Renner, U. Winter, M. Bodendorf, U. Paasch, J.C. Simon & R. Treudler. (2009) Medikamenteninduzierter Lupus erythematodes tumidus unter Adalimumab-TherapieDrug-induced lupus erythematosus tumidus during treatment with adalimumab. Der Hautarzt 60:10, pages 826-829.
Crossref
Crossref
Aharon Kessel, Itzhak Rosner, Kathy Halasz, Galia Grushko, Yehuda Shoenfeld, Dafna Paran & Elias Toubi. (2009) Antibody Clustering Helps Refine Lupus Prognosis. Seminars in Arthritis and Rheumatism 39:1, pages 66-70.
Crossref
Crossref
Jürgen Röck, Erik Schneider, Joachim R. Grün, Andreas Grützkau, Ralf Küppers, Jürgen Schmitz & Gregor Winkels. (2007) CD303 (BDCA-2) signals in plasmacytoid dendritic cellsvia a BCR-like signalosome involving Syk, Slp65 and PLCγ2. European Journal of Immunology 37:12, pages 3564-3575.
Crossref
Crossref
N. Poulalhon, E. Begon, C. Lebbé, F. Lioté, M. Lahfa, D. Bengoufa, P. Morel, L. Dubertret & H. Bachelez. (2007) A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. British Journal of Dermatology 156:2, pages 329-336.
Crossref
Crossref
L De Rycke, D Baeten, E Kruithof, F Van den Bosch, E M Veys & F De Keyser. (2016) The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus 14:12, pages 931-937.
Crossref
Crossref
Yehuda Shoenfeld & Elias Toubi. (2005) Protective autoantibodies: Role in homeostasis, clinical importance, and therapeutic potential. Arthritis & Rheumatism 52:9, pages 2599-2606.
Crossref
Crossref
Leen de Rycke, Dominique Baeten, Elli Kruithof, Filip Van den Bosch, Eric M. Veys & Filip de Keyser. (2005) Infliximab, but not etanercept, induces IgM anti–double‐stranded DNA autoantibodies as main antinuclear reactivity: Biologic and clinical implications in autoimmune arthritis. Arthritis & Rheumatism 52:7, pages 2192-2201.
Crossref
Crossref
Terry K. Means, Eicke Latz, Fumitaka Hayashi, Mandakolathur R. Murali, Douglas T. Golenbock & Andrew D. Luster. (2005) Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9. Journal of Clinical Investigation 115:2, pages 407-417.
Crossref
Crossref
Kritsana Janyapoon, Pantakit Jivakanont, Rungkarn Surbrsing, Wijitporn Siriprapapan, Thanarat Tachawuttiwat & Sunee Korbsrisate. (2005) Detection of anti-dsDNA by ELISA using different sources of antigens. Pathology 37:1, pages 63-68.
Crossref
Crossref
F Förger, T Matthias, M Oppermann, H Becker & K Helmke. (2016) Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13:1, pages 36-44.
Crossref
Crossref
Arthur F. Kavanaugh & Daniel H. Solomon. (2002) Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-DNA antibody tests. Arthritis & Rheumatism 47:5, pages 546-555.
Crossref
Crossref
Renato Tozzoli, Nicola Bizzaro, Elio Tonutti, Danilo Villalta, Danila Bassetti, Fabio Manoni, Anna Piazza, Marco Pradella & Paolo Rizzotti. (2002) Guidelines for the Laboratory Use of Autoantibody Tests in the Diagnosis and Monitoring of Autoimmune Rheumatic Diseases. American Journal of Clinical Pathology 117:2, pages 316-324.
Crossref
Crossref
A.V Kozyr, L.P Sashchenko, A.V Kolesnikov, N.A Zelenova, S.V Khaidukov, A.N Ignatova, T.V Bobik, A.G Gabibov, Z.S Alekberova, S.V Suchkov & N.V Gnuchev. (2002) Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunology Letters 80:1, pages 41-47.
Crossref
Crossref